TESA cost varies widely: brand Egrifta can run $3,000+ a month, while compounded tesamorelin and research peptides cost far less. See full pricing.
The cost of TESA (tesamorelin) in the United States ranges from roughly $40 for a single research-grade vial to more than $5,000 per month for brand-name Egrifta. Most people searching "tesa cost" are actually comparing three different markets: an FDA-approved brand drug, compounded tesamorelin from a licensed US pharmacy, and research-grade peptide labeled "for laboratory use only." Where you buy it, and whether a prescription is involved, changes the price by a factor of fifty or more.
What Is TESA?
TESA is shorthand for tesamorelin, a synthetic analog of growth hormone-releasing hormone (GHRH). It is frequently discussed alongside ipamorelin, which is why the abbreviation "tesa/ipa" appears so often in peptide forums.
The FDA approved tesamorelin as Egrifta, and later Egrifta SV, for one indication: reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Tesamorelin is not approved for general weight loss, bodybuilding, or anti-aging use.
It is a prescription drug. Human use requires a clinician's evaluation, and labs such as IGF-1 and fasting glucose are usually monitored during treatment.
TESA Cost by Source
The figures below reflect typical US cash-pay ranges. Real quotes vary by pharmacy, dose, and region.
| Source | Typical cost | Prescription needed? | Notes |
|---|---|---|---|
| Brand Egrifta SV (1.4 mg daily) | $3,000-$5,500 per 30-day supply | Yes | Manufacturer copay card can lower commercial copays |
| Brand Egrifta (2 mg daily) | $4,500-$8,000+ per month | Yes | Higher dose drives a higher price |
| Compounded tesamorelin (licensed US pharmacy) | $250-$600 per month | Yes | Not FDA-approved; potency varies by pharmacy |
| Research-grade tesamorelin (10 mg vial) | $40-$120 per vial | No, labeled "not for human use" | Purity and sterility are not guaranteed |
| Cost per milligram | $4-$12/mg (research) vs. $10-$25/mg (compounded) | - | Bulk vials lower the per-mg price |
What Drives the Price of Tesamorelin
- Dose and cycle length. A 12-week run costs far less than a six-month one, and a higher daily dose raises the total quickly.
- Brand vs. compounded. The brand product carries manufacturing, testing, and marketing costs that compounding pharmacies do not.
- Pharmacy markups and shipping. Peptides need cold-chain shipping, and overnight packaging can add $25-$60 per order.
- Medical visits and labs. Prescription programs typically add $150-$400 in baseline labs and follow-up visits.
- Supplies. Bacteriostatic water, syringes, and sharps containers add another $20-$50 per cycle.
Does Insurance Cover Tesamorelin?
Commercial insurance often covers Egrifta when the patient has a documented diagnosis of HIV-associated lipodystrophy, but prior authorization is usually required. Ryan White HIV/AIDS Program and ADAP formularies cover it in many states.
Medicare Part D and Medicaid coverage varies by plan and state. Compounded tesamorelin and research peptides are almost never covered, which makes them cash purchases.
Tesamorelin is not covered for weight loss in people who do not have HIV lipodystrophy. If a clinic advertises insurance billing for cosmetic fat loss, ask detailed questions before you pay anything.
Rule of thumb: when the prescription is written for HIV-associated lipodystrophy, coverage is realistic. When it is written for general fat loss, expect to pay out of pocket.
How TESA Cost Compares to Other Peptides and Injectables
Tesamorelin sits at the expensive end of the peptide market, which is one reason shoppers compare it with unrelated products.
| Product | Typical US cash price | FDA status |
|---|---|---|
| Egrifta SV (tesamorelin) | $3,000-$5,500 per month | Approved for HIV lipodystrophy |
| Compounded tesamorelin | $250-$600 per month | Not FDA-approved |
| AOD-9604 (research) | $3-$8 per mg | Not approved |
| Elamipretide | No standard commercial price | Not approved |
| Lipo-C injections | $100-$300 per visit | Not FDA-approved (compounded) |
| Vyleesi (bremelanotide) | About $800-$1,200 per month at list | Approved for HSDD |
Anyone asking how much does aod 9604 cost will find research vials priced at roughly $3 to $8 per milligram, a small fraction of brand tesamorelin. Elamipretide cost is hard to quote because the drug has no approved commercial version in the United States, so it mostly appears in trials and specialty compounding.
Published vyleesi cost figures land near $800 to $1,200 per month at list price, even though bremelanotide treats an unrelated condition. Lipo-C injection cost at US med spas typically runs $100 to $300 per visit, and multi-session packages lower the per-visit price further.
Ways to Lower What You Pay for TESA
- Confirm coverage and prior authorization requirements before the first prescription is filled.
- Ask the prescriber about the manufacturer copay or patient assistance program for Egrifta.
- Check whether an ADAP or Ryan White formulary applies to your situation.
- Compare two or three licensed compounding pharmacies, since pricing and testing standards differ.
- Choose the largest vial size your dose allows, which lowers the cost per milligram.
Cheaper "research use only" vials are not a legitimate way to reduce the cost of human treatment. Those products are not made under FDA oversight, sterility is not guaranteed, and the actual peptide content is rarely verified by an independent lab.
Safety and Legal Considerations
Tesamorelin can cause injection-site reactions, joint pain, carpal tunnel symptoms, fluid retention, and changes in blood sugar or IGF-1 levels. It is not a benign product, and self-dosing from a research vial removes the monitoring that makes prescription use safer.
Anyone considering tesamorelin should confirm the diagnosis with a licensed healthcare professional, review contraindications and interactions, and get baseline labs. Price should be the last variable you optimize, not the first.
RELATED PEPTIDE TOPICTesamorelin peptideFrequently Asked Questions
How much does tesamorelin cost per month?
Brand-name Egrifta and Egrifta SV typically run $3,000 to $5,500 per month at US cash prices, and higher daily doses cost more. Compounded tesamorelin from a licensed pharmacy usually falls between $250 and $600 per month. Research-grade vials sold for laboratory use are cheaper, but they are not manufactured or dosed for human use.
Is there a generic version of tesamorelin?
No FDA-approved generic tesamorelin is widely available in the United States. Compounded tesamorelin is sometimes marketed as a generic substitute, but compounded drugs are not FDA-approved and their potency can vary from one pharmacy to another. Brand Egrifta remains the only FDA-approved form of the drug.
Will insurance pay for tesamorelin?
Insurance commonly covers Egrifta for HIV-associated lipodystrophy when prior authorization and diagnosis documentation are submitted. Tesamorelin is generally not covered for weight loss, bodybuilding, or anti-aging purposes. Compounded tesamorelin and research peptides are cash-pay purchases in nearly all cases.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.